TechCrunchIntero Biosystems wants drugmakers to test on mini human intestines, not animals | TechCrunch
作者 Kate Park全文約 6,472 字
文章摘要
TechCrunch · 文章頁摘要Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Drug development has long relied on animal models, but differences between species mean what works in animals doesn’t always translate to humans, and...